Related Experiment Video
Updated: May 19, 2026
07:46
Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Systems biology: personalized medicine for the future?
1Department of Genetics, Stanford University School of Medicine, Stanford, CA 94305-5120, USA.
Current Opinion in Pharmacology
|August 4, 2012
Summary
Systems biology is revolutionizing healthcare by enabling precision medicine through integrated omics data. This approach facilitates personalized health monitoring and preventative strategies for better patient outcomes.
Area of Science:
- Systems Biology
- Genomics
- Proteomics
- Metabolomics
- Personalized Medicine
Background:
- Modern healthcare is shifting from symptom-based diagnosis to precision medicine.
- High-throughput technologies like sequencing and mass spectrometry provide detailed omics data.
- Integrated omics information enables global health and disease profiling.
Purpose of the Study:
- To review systems biology efforts in personalized medicine over the past two years.
- To discuss achievements, concerns, and future directions in personalized healthcare.
Main Methods:
- Review of recent systems biology research in personalized medicine.
- Analysis of high-throughput omics data integration.
- Discussion of technological advancements and their impact.
Main Results:
- Systems biology has significantly advanced personalized medicine through detailed omics analysis.
- Integrated omics data offers new avenues for personalized health monitoring and preventative care.
- Significant progress has been made, but challenges remain for future implementation.
Conclusions:
- Systems biology is a key driver in the transition to precision medicine.
- Continued development of high-throughput technologies is crucial for personalized healthcare.
- Addressing current hurdles will pave the way for more effective personalized health strategies.
Related Concept Videos
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...